File HB4954 ("Requires Illinois hospitals to report 340B drug discounts") is before the Illinois Legislature and has not been decided. Latest step (March 27, 2026): Rule 19(a) / Re-referred to Rules Committee.
Illinois file HB4954, before the Illinois Legislature. Still to be decided as of 2026-03-27.
Hospitals must file annual 340B participation reports by April Illinois hospitals and other 340B-eligible entities must report their drug purchases, patient counts, and program participation to the Department of Public Health each April starting 2027, with penalties for non-compliance.
State oversight may pressure drug manufacturers on pricing equity Public reporting of 340B drug dispensation patterns could expose whether hospitals are using discounts to benefit uninsured/low-income patients as intended, and may incentivize manufacturers to enforce compliance with program rules.
Creates the 340B Drug Pricing Program Reporting Act. On or before April 1, 2027 and each April 1 thereafter, requires a 340B covered entity to report the specified information and transactions to the Department of Public Health concerning the 340B covered entity's participation in or participation on behalf of the 340B covered entity in the federal 340B Program for the previous calendar year. On or before November 15, 2027 and each November 15 thereafter, requires the Department to prepare a report that aggregates the data submitted; submit the report to the General Assembly in an electronic format; and post the report on the Department's website. Provides that pharmaceutical manufacturers may request a 340B covered entity to provide specified information concerning the dispensation of 340B drugs. Sets forth provisions concerning penalties, exemptions for pharmaceutical manufacturers, and rulemaking. Provides that the Act is repealed on January 1, 2031. Effective immediately.
Read the official record for HB4954
See everything up for a vote · This week in Illinois · See what we have filed with the clerk